Xie, W., Sweeney, C., Regan, M., Nakabayashi, M., Buyse, M., Clarke, N., … Williams, S. (2016). Metastasis free survival (MFS) is a surrogate for overall survival (OS) in localized prostate cancer (CaP). Annals of Oncology, 27, vi243. https://doi.org/10.1093/annonc/mdw372.01

Xie, W., C. Sweeney, M. Regan, M. Nakabayashi, M. Buyse, N. Clarke, L. Collette, et al. “Metastasis free survival (MFS) is a surrogate for overall survival (OS) in localized prostate cancer (CaP).” Annals of Oncology 27 (October 1, 2016): vi243. https://doi.org/10.1093/annonc/mdw372.01.

Xie W, Sweeney C, Regan M, Nakabayashi M, Buyse M, Clarke N, et al. Metastasis free survival (MFS) is a surrogate for overall survival (OS) in localized prostate cancer (CaP). Annals of Oncology. 2016 Oct 1;27:vi243.

Xie, W., et al. “Metastasis free survival (MFS) is a surrogate for overall survival (OS) in localized prostate cancer (CaP).” Annals of Oncology, vol. 27, Oct. 2016, p. vi243. Scopus, doi:10.1093/annonc/mdw372.01.

Xie W, Sweeney C, Regan M, Nakabayashi M, Buyse M, Clarke N, Collette L, Dignam J, Fizazi K, Habibian M, Halabi S, Kantoff P, Parulekar W, Sandler HM, Sartor O, Soule H, Sydes M, Tombal B, Williams S. Metastasis free survival (MFS) is a surrogate for overall survival (OS) in localized prostate cancer (CaP). Annals of Oncology. 2016 Oct 1;27:vi243.